Trial intelligence / Profile preview

Calendula cream or lotion versus chamomile cream for prevention of radiodermatitis in breast cancer radiotherapy

RBR-877t2wCompleted

Sponsor
Hospital de Amor
Start
Apr 2013
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in acute radiodermatitis (ARD) comparing Chamomile cream control with Calendula cream or lotion experimental (2 arms). Primary endpoint: Prevention of grade 2 or higher acute radiation dermatitis. Started Apr 2013; status: completed.

02

Drugs

calendulachamomile
03

Conditions

acute radiodermatitis (ARD)

Beyond the preview

Go deeper on RBR-877t2w.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-877t2w.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call